FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4376608766> ?p ?o ?g. }

• W4376608766 endingPage "8" @default.
• W4376608766 startingPage "1" @default.
• W4376608766 abstract "A nationwide vaccination program against coronavirus disease 2019 (COVID-19) was started in Mongolia 4 months after the first local transmission, which occurred in November 2020. Previous studies have reported that two doses of COVID-19 vaccine result in increased antibody against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A study was conducted in Mongolia 2 weeks after the second vaccine dose. In the present study, the serum levels of antibodies of individuals 6 months after natural SARS-CoV-2 infection were compared with those of individuals who had not been infected or had been infected but had received two doses of vaccine, including BNT162b2, ChAdOx1 n-CoV-19, Gam-COVID-Vac, and BBIBP-CorV, which were used for COVID-19 in Mongolia.Of the 450 participants in this study, 237 (52.66%) were female and 213 (47.33%) were male. Four hundred people with or without SARS-CoV-2 infection who received two doses of 4 different COVID-19 vaccine participated in the vaccine groups and vaccine plus SARS-CoV-2 infection groups (50 in each group) and 50 individuals previously infected with SARS-CoV-2 participated in the unvaccinated group. Total antibody against SARS-CoV-2 infection, anti-SARS-CoV-2 N and S protein human IgG, and antibody inhibiting RBD-ACE2 binding were tested.In the BNT162b2 vaccine group, total antibody against SARS-CoV-2 remained constant until 6 months, while the other vaccine groups showed a significant decrease, as compared to the unvaccinated group. The level of anti-SARS-CoV-2 S-RBD protein IgG was significantly increased in the ChAdOx1 n-CoV-19, Gam-COVID-Vac, and BNT162b2 vaccines groups as compared to the unvaccinated group. Participants in the BNT162b2 vaccine group had higher ACE2 inhibition efficiency compared to the other vaccine groups as well as the unvaccinated group.The BNT162b2 vaccine showed the highest level of antibody against SARS-CoV-2, followed by the BBIBP-CorV, Gam-COVID-Vac, and ChAdOx1 n-CoV-19 vaccines. The level of antibodies was increased in people infected with SARS-CoV-2 after vaccination, as compared to uninfected but vaccinated individuals." @default.
• W4376608766 created "2023-05-17" @default.
• W4376608766 creator A5000648947 @default.
• W4376608766 creator A5003413953 @default.
• W4376608766 creator A5008409169 @default.
• W4376608766 creator A5020991258 @default.
• W4376608766 creator A5021995275 @default.
• W4376608766 creator A5024538287 @default.
• W4376608766 creator A5024879554 @default.
• W4376608766 creator A5030810853 @default.
• W4376608766 creator A5033382565 @default.
• W4376608766 creator A5037303202 @default.
• W4376608766 creator A5038164810 @default.
• W4376608766 creator A5039722831 @default.
• W4376608766 creator A5046143295 @default.
• W4376608766 creator A5048590415 @default.
• W4376608766 creator A5050502386 @default.
• W4376608766 creator A5051638020 @default.
• W4376608766 creator A5053311887 @default.
• W4376608766 creator A5061946383 @default.
• W4376608766 creator A5067319465 @default.
• W4376608766 creator A5079641514 @default.
• W4376608766 creator A5086954134 @default.
• W4376608766 date "2023-09-01" @default.
• W4376608766 modified "2023-09-26" @default.
• W4376608766 title "Antibody responses to mRNA versus non-mRNA COVID vaccines among the Mongolian population" @default.
• W4376608766 cites W2999364275 @default.
• W4376608766 cites W3012550011 @default.
• W4376608766 cites W3042833857 @default.
• W4376608766 cites W3045484337 @default.
• W4376608766 cites W3046490351 @default.
• W4376608766 cites W3092766467 @default.
• W4376608766 cites W3093367571 @default.
• W4376608766 cites W3095683209 @default.
• W4376608766 cites W3127329393 @default.
• W4376608766 cites W3133745688 @default.
• W4376608766 cites W3135657598 @default.
• W4376608766 cites W3163785571 @default.
• W4376608766 cites W3175897437 @default.
• W4376608766 cites W3199276937 @default.
• W4376608766 cites W3199384045 @default.
• W4376608766 cites W3211533357 @default.
• W4376608766 cites W3211888797 @default.
• W4376608766 cites W3214900982 @default.
• W4376608766 cites W3216089782 @default.
• W4376608766 cites W4200313087 @default.
• W4376608766 cites W4200455957 @default.
• W4376608766 cites W4220977324 @default.
• W4376608766 cites W4221056508 @default.
• W4376608766 cites W4224939576 @default.
• W4376608766 cites W4252031072 @default.
• W4376608766 cites W4280549068 @default.
• W4376608766 cites W4281856166 @default.
• W4376608766 cites W4283207872 @default.
• W4376608766 cites W4288176666 @default.
• W4376608766 cites W4289645892 @default.
• W4376608766 doi "https://doi.org/10.1016/j.ijregi.2023.05.002" @default.
• W4376608766 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37309454" @default.
• W4376608766 hasPublicationYear "2023" @default.
• W4376608766 type Work @default.
• W4376608766 citedByCount "0" @default.
• W4376608766 crossrefType "journal-article" @default.
• W4376608766 hasAuthorship W4376608766A5000648947 @default.
• W4376608766 hasAuthorship W4376608766A5003413953 @default.
• W4376608766 hasAuthorship W4376608766A5008409169 @default.
• W4376608766 hasAuthorship W4376608766A5020991258 @default.
• W4376608766 hasAuthorship W4376608766A5021995275 @default.
• W4376608766 hasAuthorship W4376608766A5024538287 @default.
• W4376608766 hasAuthorship W4376608766A5024879554 @default.
• W4376608766 hasAuthorship W4376608766A5030810853 @default.
• W4376608766 hasAuthorship W4376608766A5033382565 @default.
• W4376608766 hasAuthorship W4376608766A5037303202 @default.
• W4376608766 hasAuthorship W4376608766A5038164810 @default.
• W4376608766 hasAuthorship W4376608766A5039722831 @default.
• W4376608766 hasAuthorship W4376608766A5046143295 @default.
• W4376608766 hasAuthorship W4376608766A5048590415 @default.
• W4376608766 hasAuthorship W4376608766A5050502386 @default.
• W4376608766 hasAuthorship W4376608766A5051638020 @default.
• W4376608766 hasAuthorship W4376608766A5053311887 @default.
• W4376608766 hasAuthorship W4376608766A5061946383 @default.
• W4376608766 hasAuthorship W4376608766A5067319465 @default.
• W4376608766 hasAuthorship W4376608766A5079641514 @default.
• W4376608766 hasAuthorship W4376608766A5086954134 @default.
• W4376608766 hasBestOaLocation W43766087661 @default.
• W4376608766 hasConcept C126322002 @default.
• W4376608766 hasConcept C159047783 @default.
• W4376608766 hasConcept C159654299 @default.
• W4376608766 hasConcept C203014093 @default.
• W4376608766 hasConcept C22070199 @default.
• W4376608766 hasConcept C2777648638 @default.
• W4376608766 hasConcept C2779134260 @default.
• W4376608766 hasConcept C2908647359 @default.
• W4376608766 hasConcept C3007834351 @default.
• W4376608766 hasConcept C3008058167 @default.
• W4376608766 hasConcept C3018913218 @default.
• W4376608766 hasConcept C524204448 @default.
• W4376608766 hasConcept C71924100 @default.
• W4376608766 hasConcept C99454951 @default.

• next